全球胺基酸代謝紊亂治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

預計到 2032 年，全球胺基酸代謝紊亂治療市場的市場規模將從 2023 年的 7.1529 億美元達到近 11.0111 億美元，2024-2032 年研究期間的複合年成長率為 4.91%。

胺基酸代謝紊亂是遺傳性代謝疾病，通常出現在兒童時期。這些疾病會影響胺基酸的代謝，例如苯酮尿症、酪胺酸血症、高胱胺酸尿症和非酮症高甘胺酸血症等。這些疾病是體染色體隱性遺傳，可以透過分析體液中的胺基酸濃度來診斷。胺基酸代謝紊亂的治療可能包括特殊飲食、藥物和少量補充劑。血液檢查、透析和移植是胺基酸代謝紊亂的一些治療方法。

市場動態

未來，由於苯酮尿症和楓糖尿等氨基酸代謝紊亂的盛行率上升，全球氨基酸代謝紊亂治療市場預計將成長。由於氨基酸補充劑成本上升和患者不依從性，氨基酸代謝紊亂治療市場的擴張在未來幾年將放緩。家族性高膽固醇血症、戈謝氏症、亨特氏症候群、克拉伯氏症、異染性腦白質營養不良、粒線體腦病變、乳酸性酸中毒、中風樣發作（MELAS）和尼曼匹克病預計將成為胺基酸代謝紊亂治療市場的重要成長動力預測期。同樣，慢性病盛行率的上升需要更有效的治療管理以改善患者的治療效果。因此，胺基酸代謝紊亂治療市場預計在整個預測期內顯著成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球胺基酸代謝紊亂治療市場的各個細分市場進行了包容性評估。胺基酸代謝紊亂治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

胺基酸代謝紊亂治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按指示

• 精氨基琥珀學術界
• 瓜氨酸血症
• 同型胱胺酸尿症
• 苯酮尿症
• 楓糖尿病

按產品分類

• 精胺酸
• 甜菜鹼
• 卡爾格酸
• 葉酸
• 沙丙蝶呤二鹽酸鹽
• 硫胺素
• 維生素 B6 和 B12
• 維生素D

按配銷通路

• 醫院藥房
• 零售藥局
• 網路商店

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲氨基酸代謝紊亂治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。胺基酸代謝紊亂治療市場的主要參與者包括 Amino GmbH、Civentichem LLC、Koninklijke DSM NV、Kyowa Hakko Kirin Co. Ltd、Merck KGaA 和 Recordati SPA 本節包含競爭格局的整體視圖，包括各種策略發展例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：胺基酸代謝紊亂治療 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按指標進行的市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 按配銷通路分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球胺基酸代謝紊亂治療市場分析：依適應症分類

• 按指示概述
• 按指示進行歷史和預測資料分析
• 精氨基琥珀學術界
• 瓜氨酸血症
• 同型胱胺酸尿症
• 苯酮尿症
• 楓糖尿病

第 6 章：全球胺基酸代謝紊亂治療市場分析：依產品

• 概述（按產品）
• 按產品分類的歷史和預測資料分析
• 精胺酸
• 甜菜鹼
• 卡爾格酸
• 葉酸
• 沙丙蝶呤二鹽酸鹽
• 硫胺素
• 維生素 B6 和 B12
• 維生素D

第 7 章：全球胺基酸代謝紊亂治療市場分析：按分銷管道

• 配銷通路概覽
• 按配銷通路進行歷史和預測資料分析
• 醫院藥房
• 零售藥局
• 網路商店

第 8 章：全球胺基酸代謝紊亂治療市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：胺基酸代謝紊亂治療公司的競爭格局

• 胺基酸代謝紊亂治療市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• Amino GmbH
• 公司概況
• 公司收入
• 產品
• 最新動態
• Civentichem LLC
• 公司概況
• 公司收入
• 產品
• 最新動態
• Koninklijke DSM NV
• 公司概況
• 公司收入
• 產品
• 最新動態
• Kyowa Hakko Kirin Co. Ltd
• 公司概況
• 公司收入
• 產品
• 最新動態
• Merck KGaA And Recordati SPA
• 公司概況
• 公司收入
• 產品
• 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Amino Acid Metabolism Disorders Treatment Market is presumed to reach the market size of nearly USD 1101.11 Million by 2032 from USD 715.29 Million in 2023 with a CAGR of 4.91% under the study period 2024-2032.

Amino acid metabolism disorders are inherited metabolic diseases that usually manifest in childhood. These disorders affect the metabolism of amino acids such as phenylketonuria, tyrosinemia, homocystinuria, and non-ketotic hyperglycinemia among others. These disorders are autosomal recessive, and can be diagnosed by analyzing amino acid concentrations in body fluids. Amino acid metabolism disorders treatments may include special diets, medicines, and few supplements. Blood tests, dialysis and transplants are some of the amino acid metabolism disorders treatment.

MARKET DYNAMICS

In the future, the global amino acid metabolism disorders treatment market is predicted to rise due to the rising prevalence of amino acid metabolism disorders such as phenylketonuria and maple syrup urine. The expansion of the amino acid metabolism disorder therapy market would be slowed in the forthcoming years due to rising costs of amino acid supplements and patient non-compliance. Familial hypercholesterolemia, Gaucher disease, Hunter syndrome, Krabbe disease, Metachromatic leukodystrophy, Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS), and Niemann-Pick disease are expected to be significant growth drivers for the amino acid metabolism disorders treatment market over the forecast period. Again, the rising prevalence of chronic diseases necessitates more effective treatment management to enhance patient outcomes. As a result, the amino acid metabolism disorders therapy market is expected to increase significantly throughout the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Amino Acid Metabolism Disorders Treatment. The growth and trends of Amino Acid Metabolism Disorders Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Amino Acid Metabolism Disorders Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

• Argininosuccinic Academia
• Citrullinemia
• Homocystinuria
• Phenylketonuria
• Maple Syrup Urine Disease

By Product

• Arginine
• Betaine
• Carglumic Acid
• Folic Acid
• Sapropterin Dihydrochloride
• Thiamine
• Vitamin B6 and B12
• Vitamin D

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Stores

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Amino Acid Metabolism Disorders Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Amino Acid Metabolism Disorders Treatment market include Amino GmbH, Civentichem LLC, Koninklijke DSM N.V., Kyowa Hakko Kirin Co. Ltd, Merck KGaA And Recordati S.P.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. AMINO ACID METABOLISM DISORDERS TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Indication
  • 3.7.2 Market Attractiveness Analysis By Product
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY INDICATION

• 5.1. Overview By Indication
• 5.2. Historical and Forecast Data Analysis By Indication
• 5.3. Argininosuccinic Academia Historic and Forecast Sales By Regions
• 5.4. Citrullinemia Historic and Forecast Sales By Regions
• 5.5. Homocystinuria Historic and Forecast Sales By Regions
• 5.6. Phenylketonuria Historic and Forecast Sales By Regions
• 5.7. Maple Syrup Urine Disease Historic and Forecast Sales By Regions

6. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY PRODUCT

• 6.1. Overview By Product
• 6.2. Historical and Forecast Data Analysis By Product
• 6.3. Arginine Historic and Forecast Sales By Regions
• 6.4. Betaine Historic and Forecast Sales By Regions
• 6.5. Carglumic Acid Historic and Forecast Sales By Regions
• 6.6. Folic Acid Historic and Forecast Sales By Regions
• 6.7. Sapropterin Dihydrochloride Historic and Forecast Sales By Regions
• 6.8. Thiamine Historic and Forecast Sales By Regions
• 6.9. Vitamin B6 and B12 Historic and Forecast Sales By Regions
• 6.10. Vitamin D Historic and Forecast Sales By Regions

7. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 7.1. Overview By Distribution Channel
• 7.2. Historical and Forecast Data Analysis By Distribution Channel
• 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
• 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
• 7.5. Online Stores Historic and Forecast Sales By Regions

8. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AMINO ACID METABOLISM DISORDERS TREATMENT COMPANIES

• 9.1. Amino Acid Metabolism Disorders Treatment Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF AMINO ACID METABOLISM DISORDERS TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Amino GmbH
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Civentichem LLC
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Koninklijke DSM N.V.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Kyowa Hakko Kirin Co. Ltd
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Merck KGaA And Recordati S.P.A
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Indication (USD MN)
• Argininosuccinic Academia Market Sales By Geography (USD MN)
• Citrullinemia Market Sales By Geography (USD MN)
• Homocystinuria Market Sales By Geography (USD MN)
• Phenylketonuria Market Sales By Geography (USD MN)
• Maple Syrup Urine Disease Market Sales By Geography (USD MN)
• Analysis By Product (USD MN)
• Arginine Market Sales By Geography (USD MN)
• Betaine Market Sales By Geography (USD MN)
• Carglumic Acid Market Sales By Geography (USD MN)
• Folic Acid Market Sales By Geography (USD MN)
• Sapropterin Dihydrochloride Market Sales By Geography (USD MN)
• Thiamine Market Sales By Geography (USD MN)
• Vitamin B6 and B12 Market Sales By Geography (USD MN)
• Vitamin D Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Online Stores Market Sales By Geography (USD MN)
• Global Amino Acid Metabolism Disorders Treatment Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Amino Acid Metabolism Disorders Treatment Report
• Market Research Process
• Market Research Methodology
• Global Amino Acid Metabolism Disorders Treatment Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Indication
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Indication (USD MN)
• Argininosuccinic Academia Market Sales By Geography (USD MN)
• Citrullinemia Market Sales By Geography (USD MN)
• Homocystinuria Market Sales By Geography (USD MN)
• Phenylketonuria Market Sales By Geography (USD MN)
• Maple Syrup Urine Disease Market Sales By Geography (USD MN)
• Global Market Analysis By Product (USD MN)
• Arginine Market Sales By Geography (USD MN)
• Betaine Market Sales By Geography (USD MN)
• Carglumic Acid Market Sales By Geography (USD MN)
• Folic Acid Market Sales By Geography (USD MN)
• Sapropterin Dihydrochloride Market Sales By Geography (USD MN)
• Thiamine Market Sales By Geography (USD MN)
• Vitamin B6 and B12 Market Sales By Geography (USD MN)
• Vitamin D Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Online Stores Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.